美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

603538 美诺华

已收盘 09-11 15:00:00

{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":25.42,"timestamp":1789110000000,"preClose":26.46,"halted":0,"volume":27367576,"delay":0,"changeRate":-0.0393,"floatShares":337000000,"shares":340000000,"eps":0.3438,"marketStatus":"已收盘","change":-1.04,"latestTime":"09-11 15:00:00","open":25.97,"high":26.1,"low":25.08,"amount":696000000,"amplitude":0.0385,"askPrice":25.43,"askSize":222,"bidPrice":25.42,"bidSize":60,"shortable":0,"etf":0,"ttmEps":0.3438,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":5,"adr":0,"adjPreClose":26.46,"symbolType":"stock","openAndCloseTimeList":[[1789090200000,1789097400000],[1789102800000,1789110000000]],"highLimit":29.11,"lowLimit":23.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":339928188,"isCdr":false,"pbRate":2.95,"roa":"--","peRate":73.938336,"roe":"2.42%","epsLYR":0.48,"committee":0.625261,"marketValue":8641000000,"turnoverRate":0.0812,"status":1,"floatMarketCap":8565000000},"requestUrl":"/m/hq/s/603538/wiki","defaultTab":"wiki","newsList":[{"id":"2665365889","title":"每周股票复盘：美诺华（603538）定增方案获股东会通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365889","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665365889?lang=zh_cn&edition=full","pubTime":"2026-09-06 01:06","pubTimestamp":1788627973,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，美诺华报收于27.32元，较上周的27.3元上涨0.07%。本周，美诺华9月4日盘中最高价报29.2元。本周共计1次涨停收盘，无跌停收盘情况。美诺华当前最新总市值92.87亿元，在化学制药板块市值排名52/149，在两市A股市值排名1930/5214。本周关注点公司公告汇总：美诺华2026年第二次临时股东会审议通过向特定对象发行A股股票相关议案。会议由董事会召集，采取现场与网络投票相结合方式举行，表决程序合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600000063.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664338075","title":"美诺华（603538）披露2026年度向特定对象发行A股股票方案，9月4日股价下跌4.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664338075","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664338075?lang=zh_cn&edition=full","pubTime":"2026-09-04 17:28","pubTimestamp":1788514116,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，美诺华报收于27.32元，较前一交易日下跌4.11%，最新总市值为92.87亿元。近日，宁波美诺华药业股份有限公司披露《2026年第二次临时股东会决议公告》。公告显示，公司于2026年9月3日召开2026年第二次临时股东会，审议通过了《关于公司符合向特定对象发行A股股票条件的议案》《关于公司2026年度向特定对象发行A股股票方案的议案》等11项议案，所有议案均获通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400030478.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02827","603538","159982","03130","82846","07233","83130","399300","83188","BK1147","BK0239","02846","03188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664480839","title":"美诺华：2026年第二次临时股东会决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2664480839","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664480839?lang=zh_cn&edition=full","pubTime":"2026-09-03 22:02","pubTimestamp":1788444120,"startTime":"0","endTime":"0","summary":"证券日报网讯9月3日，美诺华（维权）发布公告称，公司于2026年9月3日召开2026年第二次临时股东会，审议通过《关于公司符合向特定对象发行A股股票条件的议案》等多项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqncq1860855.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-03/doc-iniqqncq1860855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664282053","title":"9月3日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664282053","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664282053?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:37","pubTimestamp":1788424636,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日美诺华涨10.00%，收盘报28.49元，换手率19.27%，成交量64.92万手，成交额17.99亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为37.96%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300030047.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664823368","title":"异动快报：美诺华（603538）9月3日10点23分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2664823368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664823368?lang=zh_cn&edition=full","pubTime":"2026-09-03 10:25","pubTimestamp":1788402328,"startTime":"0","endTime":"0","summary":"证券之星9月3日盘中消息，10点23分美诺华（603538）触及涨停板。其所属行业化学制药目前下跌。领涨股为亚虹医药。该股为减肥药，辅助生殖，新冠病毒防治概念热股，当日减肥药概念上涨0.34%。9月2日的资金流向数据方面，主力资金净流出2120.24万元，占总成交额3.9%，游资资金净流入1099.24万元，占总成交额2.02%，散户资金净流入1021.0万元，占总成交额1.88%。近5日资金流向一览见下表：美诺华主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300013168.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664942598","title":"美诺华：由公司的技术合作方完成的有关JH389功效比对验证试验结论表明","url":"https://stock-news.laohu8.com/highlight/detail?id=2664942598","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664942598?lang=zh_cn&edition=full","pubTime":"2026-09-02 15:34","pubTimestamp":1788334462,"startTime":"0","endTime":"0","summary":"请问贵公司明确这次头对头实验成果和结论！谢谢美诺华回复：尊敬的投资者您好由公司的技术合作方完成的有关JH389功效比对验证试验结论表明：其效果趋于一致。同时提请关注以下风险点：1、该试验结论仅为针对动物小鼠，为期五周的对比实验的结果，实验具有局限性；2、JH389的注册时间、商业化时间存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090200022499.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663456460","title":"每周股票复盘：美诺华（603538）拟募资不超21.09亿投建制剂项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2663456460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663456460?lang=zh_cn&edition=full","pubTime":"2026-08-30 09:46","pubTimestamp":1788054373,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，美诺华报收于27.3元，较上周的28.51元下跌4.24%。本周，美诺华8月25日盘中最高价报27.9元。美诺华当前最新总市值92.8亿元，在化学制药板块市值排名53/149，在两市A股市值排名1951/5211。本周关注点公司公告汇总：美诺华拟向特定对象发行A股，募集资金不超过210,856万元用于高端制剂项目建设及补充流动资金。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004670.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662406191","title":"美诺华：所得税费用变动原因","url":"https://stock-news.laohu8.com/highlight/detail?id=2662406191","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662406191?lang=zh_cn&edition=full","pubTime":"2026-08-28 18:21","pubTimestamp":1787912512,"startTime":"0","endTime":"0","summary":"美诺华回复：投资者您好，所得税费用的变动原因，主要为以下原因所致：1、本期利润总额增加，较同期增长49.86%；2、本期可转债完成转股及部分赎回，可转债在金融负债与权益工具之间进行重分类调整，产生暂时性差异，相应计提递延所得税，进一步推高当期所得税费用；3、股权激励计划项下限制性股票本期解禁，解禁日股票市场公允价格高于前期授予价格，需确认对应可抵扣暂时性差异，而计提递延所得税费用。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800043311.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662065471","title":"美诺华：JH389的全球注册方面，欧洲地区目前不计划进行Novel Food申报","url":"https://stock-news.laohu8.com/highlight/detail?id=2662065471","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662065471?lang=zh_cn&edition=full","pubTime":"2026-08-28 17:36","pubTimestamp":1787909768,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华08月28日在投资者关系平台上答复投资者关心的问题。围绕益生菌全球化，覆盖美国GRAS&NDI、加拿大NHP加拿大NHP、澳大利亚TGA及欧盟NovelFood等核心探讨认证。贵公司暂没考虑欧盟NovelFood注册吧？谢谢美诺华回复：尊敬的投资者您好，感谢您的关心。JH389的全球注册方面，欧洲地区目前不计划进行Novel Food申报，整体申报仍由欧洲合作伙伴协助推进；美国地区的GRAS整体申报工作由美安康协助推进，双方亦就全球其他核心地区的准入进行了深入探讨。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800040384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662717497","title":"美诺华（603538）披露向特定对象发行A股股票预案，8月26日股价下跌2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662717497","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662717497?lang=zh_cn&edition=full","pubTime":"2026-08-26 22:02","pubTimestamp":1787752942,"startTime":"0","endTime":"0","summary":"截至2026年8月26日收盘，美诺华报收于26.16元，较前一交易日下跌2.97%，最新总市值为88.93亿元。该股当日开盘26.95元，最高27.8元，最低25.93元，成交额达11.17亿元，换手率为12.5%。近日，宁波美诺华药业股份有限公司披露2026年第二次临时股东会会议资料，拟召开临时股东大会审议关于向特定对象发行A股股票相关议案，包括发行方案、预案、募集资金使用可行性分析、摊薄即期回报填补措施等。本次发行拟募集资金不超过210,856万元，用于项目建设和补充流动资金。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082600051618.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02846","83130","BK0239","399300","07233","83188","03130","03188","02827","82846","159982","BK1147","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661221404","title":"8月24日美诺华跌7.40%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2661221404","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661221404?lang=zh_cn&edition=full","pubTime":"2026-08-24 16:31","pubTimestamp":1787560298,"startTime":"0","endTime":"0","summary":"证券之星消息，8月24日美诺华跌7.40%，收盘报26.4元，换手率19.65%，成交量66.22万手，成交额17.49亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为38.36%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400021790.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661963263","title":"美诺华：JH389的欧洲注册是公司同欧洲合作方共同推进的","url":"https://stock-news.laohu8.com/highlight/detail?id=2661963263","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661963263?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:09","pubTimestamp":1787299755,"startTime":"0","endTime":"0","summary":"JH389的欧洲注册是公司同欧洲合作方共同推进的，目前已与EFSA进行了数轮预沟通。受欧洲合作方安排影响，目前仍有一项注册前的安全性试验正在进行中。截至目前，无论是已完成的试验、尚在进行的试验，还是与EFSA的沟通，均未收到任何关于安全性或技术性的负面反馈。此后，JH389将成为美诺华独有的特色创新管线产品。本次收购充分体现了公司对JH389项目的坚定推进决心，未来将更高效地统筹项目的生产、注册及销售布局，力争尽快实现销售收入。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100026444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661531263","title":"美诺华：默沙东新合作品种正不断进入","url":"https://stock-news.laohu8.com/highlight/detail?id=2661531263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661531263?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:00","pubTimestamp":1787299253,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华08月21日在投资者关系平台上答复投资者关心的问题。默沙东的业务今年有不错的进展，主要是前期的一个大产品已经进入了商业化阶段。新合作品种正在不断进入，公司将进一步深化与默沙东的战略合作关系，成为亚太地区创新性小分子药物的核心生产基地，业绩会逐步兑现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100025565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256352","title":"异动快报：美诺华（603538）8月21日9点33分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661256352?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:35","pubTimestamp":1787276133,"startTime":"0","endTime":"0","summary":"证券之星8月21日盘中消息，9点33分美诺华（603538）触及跌停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为辅助生殖，新冠病毒防治，合成生物概念热股。8月20日的资金流向数据方面，主力资金净流入1.31亿元，占总成交额4.92%，游资资金净流出4684.48万元，占总成交额1.77%，散户资金净流出8367.78万元，占总成交额3.15%。近5日资金流向一览见下表：美诺华主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100010801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660740245","title":"8月20日美诺华涨5.85%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660740245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660740245?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:35","pubTimestamp":1787214910,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日美诺华涨5.85%，收盘报31.68元，换手率25.25%，成交量85.08万手，成交额26.53亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为43.1%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473498","title":"美诺华（603538）披露召开2026年第二次临时股东会通知，8月18日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660473498?lang=zh_cn&edition=full","pubTime":"2026-08-18 22:04","pubTimestamp":1787061895,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，美诺华报收于30.75元，较前一交易日下跌1.25%，最新总市值为104.53亿元。该股当日开盘31.15元，最高32.28元，最低30.53元，成交额达17.97亿元，换手率为17.15%。近日，宁波美诺华药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年9月3日召开2026年第二次临时股东会，会议采用现场投票与网络投票相结合的方式，网络投票通过上海证券交易所系统进行。股权登记日为2026年8月27日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800042145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660880105","title":"【机构调研记录】银河基金调研美诺华、多利科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2660880105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660880105?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:01","pubTimestamp":1786924902,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月14日披露的机构调研信息，银河基金近期对2家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。集采推动制剂放量，成为营收增长核心原因。2）多利科技 调研纪要：随着一体化压铸业务规模逐步扩大，产品结构更趋丰富，规模效应将逐步显现，盈利能力有望持续改善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0264","001311","BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660058381","title":"【机构调研记录】华宝基金调研美诺华、多利科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2660058381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660058381?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:01","pubTimestamp":1786924884,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月14日披露的机构调研信息，华宝基金近期对2家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。集采推动制剂放量，成为营收增长核心原因。2）多利科技 调研纪要：随着一体化压铸业务规模逐步扩大，产品结构更趋丰富，规模效应将逐步显现，盈利能力有望持续改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0264","BK0239","001311","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660891105","title":"【私募调研记录】玄卜投资调研美诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660891105?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:00","pubTimestamp":1786924859,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月14日披露的机构调研信息，知名私募玄卜投资近期对1家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。CDMO订单因默沙东及新冠创新药业务增长而提升，短期资本开支不大，研发投入将逐步上升。公司强调以披露信息为准，提醒投资者不信谣不传谣。机构简介：玄卜投资（上海）有限公司成立于2014年，注册资本为人民币4,500万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081700001556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660210586","title":"【私募调研记录】季胜投资调研美诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2660210586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660210586?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:00","pubTimestamp":1786924855,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月14日披露的机构调研信息，知名私募季胜投资近期对1家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。CDMO订单因默沙东及新冠创新药业务增长而提升，短期资本开支不大，研发投入将逐步上升。公司强调以披露信息为准，提醒投资者不信谣不传谣。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081700001548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1789331763332,"stockEarnings":[{"period":"1week","weight":-0.0695},{"period":"1month","weight":-0.2373},{"period":"3month","weight":-0.0696},{"period":"6month","weight":0.4082},{"period":"1year","weight":0.4553},{"period":"ytd","weight":0.857}],"compareEarnings":[{"period":"1week","weight":-0.0107},{"period":"1month","weight":-0.0148},{"period":"3month","weight":-0.0356},{"period":"6month","weight":-0.0506},{"period":"1year","weight":0.0033},{"period":"ytd","weight":-0.0203}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44076人(较上一季度减少15.96%)","perCapita":"7644股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区菁华路777号1号楼7楼","registeredCapital":"33992万元","survey":"　　宁波美诺华药业股份有限公司的主营业务是特色原料药和制剂研发、生产与销售。公司的主要产品是医药中间体、原料药、制剂。公司是中国化学制药百强企业、宁波市制造业百强企业、宁波竞争力百强企业、浙江省成长最快百强企业。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}